ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cells"

  • 2015 American Transplant Congress

    Donor Specific Expansion of Regulatory T-Cells Was Associated With Allograft Tolerance Induced By Transient Mixed Chimerism in Nonhuman Primates

    K. Hotta, A. Aoyama, T. Ohura, M. Tonsho, Y. Yamada, J. Allan, J. Madsen, B. Cosimi, G. Benichou, T. Kawai.

    Transplant Center, Massachusetts General Hospital, Boston, MA.

    Background: We have previously reported successful induction of solid organ allograft tolerance in nonhuman primates (NHP) via a mixed chimerism approach. Since these recipients achieved…
  • 2015 American Transplant Congress

    Interleukin-17A Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function

    K. Sivanathan,1,2,3 D. Rojas-Canales,1,2 S. Grey,5 C. Hope,1,2 R. Carroll,1,4 S. Gronthos,3,6 P. Coates.1,2,3,4

    1Centre for Clinical and Experimental Transplantation, Royal Adelaide Hospital, Adelaide, South Australia, Australia; 2School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia; 3Centre for Stem Cell Research, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia; 4Central Northern Adelaide Renal Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia; 5Transplantation Immunology Group, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia; 6Mesenchymal Stem Cell Laboratory, School of Medical Sciences, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia.

    Interferon-gamma preactivated mesenchymal stem cells (MSC-γ) are highly immunosuppressive but immunogenic in vivo due to their inherent expression of major histocompatibility (MHC) molecules. We modified…
  • 2015 American Transplant Congress

    The Immunosuppressive Effect of CTLA4Ig Monotherapy Depends On the Presence of Tregs Only at Suboptimally Low Doses

    C. Schwarz,1 L. Unger,1 B. Mahr,1 K. Aumayr,2 N. Pilat,1 K. Hock,1 A. Farkas,1 I. Kristo,1 T. Wekerle.1

    1Dept. of Surgery, Medical University of Vienna, Vienna, Austria; 2Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.

    Background: CTLA4Ig/belatacept has been recently approved for immunosuppression after renal transplantation. Concerns persist, however, that a paradoxical dose-response relationship might exist for CTLA4Ig in which…
  • 2015 American Transplant Congress

    ALDH Expression in Facilitating Cells Plays a Critical Role in Regulatory T Cell Induction and GVHD Prevention

    H. Xu,1 T. Miller,1 Y. Huang,1 S. Ildstad.1,2

    1Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; 2Regenerex, LLC, Louisville, KY.

    Graft-vs-host disease (GVHD) is a major source of morbidity in hematopoietic stem cell transplantation (HSCT), limiting its application to treat nonmalignant hematopoietic diseases and to…
  • 2015 American Transplant Congress

    Induction of iNOS Expressed Macrophages from Mouse iPS cells That Contribute to Prolong Same iPS Cells-Derived Graft Survival in Allogeneic Recipients

    H. Sasaki,1 H. Wada,2 K. Morita,1 K.-I. Seino,2 N. Shinohara.1

    1Genitourinary Surgery, Hokkaido University, Sapporo, Japan; 2Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

    BACKGROUND: Induced pluripotent stem cells (iPSCs)-technology provides new opportunities in regenerative medicine to generate grafts from donors for transplantation. However, particularly when allogeneic iPSCs are…
  • 2015 American Transplant Congress

    T Cell Specific Up Regulation of Nrf2 Regulated Antioxidant Response Protects from Kidney Ischemia Reperfusion Injury in Mice

    S. Noel,1 M. Martina,2 S. Bandapalle,1 S. Reddy,3 L. Racusen,2 A. Hamad,2 H. Rabb.1

    1Department of Medicine, Johns Hopkins University, Baltimore, MD; 2Department of Pathology, Johns Hopkins University, Baltimore, MD; 3Department of Pediatrics, University of Illinois, Chicago, IL.

    Background: T lymphocytes mediate important pathophysiological roles during ischemia reperfusion injury (IRI). Transcription factor Nrf2 is protective during experimental kidney IRI and thought to be…
  • 2015 American Transplant Congress

    Lymphotoxin Controls Treg Interactions With Lymphatic Endothelial Cells and Interstitial Migration In Vivo

    C. Brinkman, Y. Xiong, S. Ahmad, J. Bromberg.

    University of Maryland, Baltimore, MD.

    Introduction: Lymphotoxin (LT) coordinates the development, organization and structure of lymphoid organs, and LTβreceptor (LTβR) is involved in thymocyte migration. However, LT has no described…
  • 2015 American Transplant Congress

    T Cell Transfer With iNKT Cell Activation Facilitate Engraftment of Bone Marrow Cells Without GvHD

    R. Ishii,1 T. Hirai,1 S. Miyairi,1 M. Ikemiyagi,1 K. Omoto,1 Y. Ishii,2 K. Tanabe.1

    1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Laboratory of Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

    Contamination of allogenic T cells is considered to be a risk factor of graft versus host disease (GvHD) in bone marrow transplantation (BMT), whereas it…
  • 2015 American Transplant Congress

    IFNγ Is Required for nTreg Afferent Lymphatic Migration

    S. Ahmad, Y. Xiong, C. Brinkman, J. Bromberg.

    Surgery, University of Maryland, Baltimore, MD.

    Background: Natural Treg (nTreg) must migrate from graft to draining lymph node (LN) to prolong islet allograft survival, and we previously showed that the transcription…
  • 2015 American Transplant Congress

    Structure/Function Insights Into Treg Biology: Hdac11 Is a Foxp3 Deacetylase Whose Targeting Promotes and Stabilizes Foxp3 Expression and Leads to Long-Term Allograft Survival

    J. Huang,1 L. Wang,1 T. Bhatti,1 A. Samanta,1 S. Dahiya,1 R. Han,1 J. Bergman,2 A. Kozikowski,2 W. Hancock.1

    1CHOP & UPenn, Philadelphia; 2Uni of Illinois at Chicago, Chicago.

    Aim: There are huge scientific, economic and practical advantages in developing pharmacologic approaches to enhance Foxp3+ Treg function in allograft recipients versus simply injecting enormous…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences